Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AR | P10275 | 3/20 | 1.00 |
| ▸ | ABCG2 | Q9UNQ0 | 3/20 | 1.00 |
| ▸ | ABCB1 | P08183 | 1/20 | 1.00 |
| ▸ | MAOB | P27338 | 10/20 | 0.80 |
| ▸ | CYP19A1 | P11511 | 6/20 | 0.80 |
| ▸ | NPC1 | O15118 | 2/20 | 0.73 |
| ▸ | MAPT | P10636 | 2/20 | 0.73 |
| ▸ | RAB9A | P51151 | 2/20 | 0.73 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.71 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.71 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.71 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.71 |
| ▸ | GAA | P10253 | 1/20 | 0.71 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.71 |
| ▸ | TSHR | P16473 | 1/20 | 0.71 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.69 |
| ▸ | STS | P08842 | 1/20 | 0.69 |
| ▸ | HPGD | P15428 | 1/20 | 0.63 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.61 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL126192 | 1.00 | AR (1.00) | ARABCG2ABCB1MAOBCYP19A1 | |
| SCHEMBL22680315 | 0.93 | ABCB1 (0.87) | ARABCG2ABCB1MAOBCYP19A1 | |
| SCHEMBL29020378 | 0.90 | ABCB1 (0.82) | ARABCG2ABCB1MAOBCYP19A1 | |
| SCHEMBL30499387 | 0.90 | ABCB1 (0.82) | ARABCG2ABCB1MAOBCYP19A1 | |
| SCHEMBL12067063 | 0.89 | ABCB1 (0.81) | ARABCG2ABCB1MAOBCYP19A1 | |
| SCHEMBL1895399 | 0.89 | MAOB (1.00) | ARABCG2ABCB1MAOBCYP19A1 | |
| SCHEMBL131515 | 0.89 | MAOB (1.00) | ARABCG2ABCB1MAOBCYP19A1 | |
| SCHEMBL30777574 | 0.88 | MAOB (0.81) | ARABCG2ABCB1MAOBCYP19A1 | |
| SCHEMBL18893710 | 0.88 | MAOB (0.81) | ARABCG2ABCB1MAOBCYP19A1 | |
| SCHEMBL1823145 | 0.86 | AR (0.76) | ARABCG2ABCB1MAOBCYP19A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230172901-A1 | COMPOSITIONS AND METHODS FOR THE PROPHYLAXIS AND TREATMENT OF FIBROTIC AND INFLAMMATORY CONDITIONS | GRETALS AUSTRALIA PTY LTD (AU) | 2023-06-08 | — | — | US | claimed |
| EP-4146194-A1 | COMPOSITIONS AND METHODS FOR THE PROPHYLAXIS AND TREATMENT OF FIBROTIC AND INFLAMMATORY CONDITIONS | Gretals Australia Pty Ltd (AU) | 2023-03-15 | — | — | EP | claimed |
| WO-2021222987-A1 | COMPOSITIONS AND METHODS FOR THE PROPHYLAXIS AND TREATMENT OF FIBROTIC AND INFLAMMATORY CONDITIONS | GRETALS AUSTRALIA PTY LTD (AU) | 2021-11-11 | — | — | WO | claimed |
| WO-2025091065-A1 | FLAVONOID COMPOSITION | GRETALS AUSTRALIA PTY LTD (AU) | 2025-05-08 | — | — | WO | disclosed |
| US-20230172901-A1 | COMPOSITIONS AND METHODS FOR THE PROPHYLAXIS AND TREATMENT OF FIBROTIC AND INFLAMMATORY CONDITIONS | GRETALS AUSTRALIA PTY LTD (AU) | 2023-06-08 | — | — | US | disclosed |
| EP-4146194-A1 | COMPOSITIONS AND METHODS FOR THE PROPHYLAXIS AND TREATMENT OF FIBROTIC AND INFLAMMATORY CONDITIONS | Gretals Australia Pty Ltd (AU) | 2023-03-15 | — | — | EP | disclosed |
| CN-115135199-A | Method and system for multi-layer cosmetic pad and use thereof | ELC 管理有限责任公司 | 2022-09-30 | — | — | CN | disclosed |
| WO-2021222987-A1 | COMPOSITIONS AND METHODS FOR THE PROPHYLAXIS AND TREATMENT OF FIBROTIC AND INFLAMMATORY CONDITIONS | GRETALS AUSTRALIA PTY LTD (AU) | 2021-11-11 | — | — | WO | disclosed |
| CN-110652975-B | (S) -BINOL derivative CSP filler and preparation method and application thereof | 昆明医科大学 | 2021-10-26 | — | — | CN | disclosed |
| CN-110652975-A | (S) -BIONL derivative CSP filler and preparation method and application thereof | 昆明医科大学 | 2020-01-07 | — | — | CN | disclosed |
| CN-109890378-A | FOXO1 activity-inhibiting composition | 三得利控股株式会社 | 2019-06-14 | — | — | CN | disclosed |
| EP-1869200-B1 | ENZYMATIC DEMETHYLATION OF FLAVONOIDS | UNIV GENT (BE) | 2008-09-03 | — | — | EP | disclosed |
| EP-1869200-A1 | ENZYMATIC DEMETHYLATION OF FLAVONOIDS | UNIVERSITEIT GENT (BE) | 2007-12-26 | — | — | EP | disclosed |
| EP-1625150-B9 | TRIPEPTIDES AND DERIVATIVES THEREOF FOR COSMETIC APPLICATION IN ORDER TO IMPROVE SKIN STRUCTURE | PENTAPHARM AG (CH) | 2007-06-13 | — | — | EP | disclosed |
| EP-1625150-B1 | TRIPEPTIDES AND DERIVATIVES THEREOF FOR COSMETIC APPLICATION IN ORDER TO IMPROVE SKIN STRUCTURE | PENTAPHARM AG (CH) | 2007-01-03 | — | — | EP | disclosed |
| WO-2006099699-A1 | ENZYMATIC DEMETHYLATION OF FLAVONOIDS | UNIVERSITEIT GENT (BE) | 2006-09-28 | — | — | WO | disclosed |
| EP-1625150-A1 | TRIPEPTIDES AND DERIVATIVES THEREOF FOR COSMETIC APPLICATION IN ORDER TO IMPROVE SKIN STRUCTURE | Pentapharm AG (CH) | 2006-02-15 | — | — | EP | disclosed |
| WO-2004099237-A1 | TRIPEPTIDES AND DERIVATIVES THEREOF FOR COSMETIC APPLICATION IN ORDER TO IMPROVE SKIN STRUCTURE | PENTAPHARM AG (CH) | 2004-11-18 | — | — | WO | disclosed |
| WO-2003057210-A1 | COMPOSITIONS AND METHODS FOR INCREASING CELL PROLIFERATION COMPRISING A FLAVONOID | KIMBERLY-CLARK WORLDWIDE, INC. (US) | 2003-07-17 | — | — | WO | disclosed |
| US-20030125264-A1 | Methods For Treating Wounds | KIMBERLY-CLARK WORLDWIDE, INC. | 2003-07-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030125264-A1 | Methods For Treating Wounds | FGF2, MMP1, FIBP | AR 3549/4885ABCG2 3752/4885ABCB1 2498/4885 |
| US-20230172901-A1 | COMPOSITIONS AND METHODS FOR THE PROPHYLAXIS AND TREATMENT OF FIBROTIC AND INFLAMMATORY CONDITIONS | MMP1, COL1A1, SERPINB1 | AR 3364/4885ABCG2 4063/4885ABCB1 2698/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.